PCR52 Use of Patient Reported Outcomes in Key Trials Supporting Marketing Authorisation: 5-Year Analysis of Company Evidence Submitted for National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2491
https://www.valueinhealthjournal.com/article/S1098-3015(23)05621-8/fulltext
Title :
PCR52 Use of Patient Reported Outcomes in Key Trials Supporting Marketing Authorisation: 5-Year Analysis of Company Evidence Submitted for National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05621-8&doi=10.1016/j.jval.2023.09.2491
First page :
Section Title :
Open access? :
No
Section Order :
11833